In Brief: Healthdyne
This article was originally published in The Gray Sheet
Executive Summary
Healthdyne: European launch of disposable, single-use probe for non-invasive fetal oximetry is slated for late 1997, President and CEO Craig Reynolds says June 18 at the Dillon, Read & Company medical technology conference in New York City. A U.S. launch will follow FDA clearance of a premarket approval application. The device gives a "direct measurement of oxygen, it gives...a quantitative number," the exec said. Reynolds originally predicted a 1997 U.S. launch for the system at a December 1995 investor's conference ("The Gray Sheet I&W-11)...